Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
about
Toxicity of amphetamines: an updateNeural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications.Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamineThe effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studiesThe influence of genetic and environmental factors among MDMA users in cognitive performanceEcstasy exposure & gender: examining components of verbal memory functioningPrior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.Glucose and corticosterone changes in developing and adult rats following exposure to (+/-)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine.The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.Neuropsychological deficits in adolescent methamphetamine abusers.Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperaturePsychiatric symptoms and HPA axis function in adolescent methamphetamine usersBrain serotonin function in MDMA (ecstasy) users: evidence for persisting neurotoxicity.Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.ITI-007 demonstrates brain occupancy at serotonin 5-HT₂A and dopamine D₂ receptors and serotonin transporters using positron emission tomography in healthy volunteers.Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users.Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug usersInferring about individual drug and schizotypy effects on cognitive functioning in polydrug using mephedrone users before and after clubbing.Human Ecstasy use is associated with increased cortical excitability: an fMRI study.Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys.Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans.MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI studyMDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity.Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humansN-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.Polymorphisms in the 5-HTTLPR gene mediate storage capacity of visual working memorySustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans.MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampusGenetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning.Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processingEffects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats.Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration.Preliminary evidence of motor impairment among polysubstance 3,4-methylenedioxymethamphetamine users with intact neuropsychological functioningDevelopmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK.The effects of 'ecstasy' (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses.Neuropathology of substance use disorders.
P2860
Q22252794-CFA171AC-5D4B-4529-AED8-CD62C3862621Q24619949-AAFCACBA-EAA7-46F1-AF29-16F071910C4CQ26823158-778F3890-722E-48C9-9050-B9D5B338CEFDQ26858946-4DCD4AAE-73F2-4AF2-A253-676BCC11E5F8Q28069364-E6E64DE9-9F21-4113-B896-56F4F1F083E5Q28477994-59F428C8-0A1B-4CB7-8E11-DE9DA379303BQ28542888-503E727D-0477-4268-84B4-AA80EF61C93AQ33586450-FF58DD50-9A9C-4CB6-8FB1-B009E79EFD81Q33729739-BE97CA95-A9A1-4F52-8D4E-CC1B1886AE46Q34025177-02C25971-DA40-4E2D-941E-065EF17BC426Q34030711-72DA8AEC-9508-473E-AD60-A84EE2762CA3Q34126453-B5FC7D71-E522-4455-B5B0-25E834B10262Q34214693-4455A4D9-88D6-4569-9655-5F7A98275779Q34283177-7C7F056D-3BBC-4382-84D6-F95F8DD0B1E7Q34311373-EA08F907-53F9-4251-833A-3AF9F208E63CQ34359604-2414590B-B18C-491F-9F19-F27E37531975Q34470362-1B5BCFA5-DA19-4E0E-972D-A8BE8FACDEB2Q34569376-174EA039-A614-404C-8E57-F8C56BFB3048Q34618285-C194CE5F-217D-488E-8893-C6156CA79486Q34634128-F9DDE023-F849-450B-953E-7EF5490FF530Q34637364-94155B51-E4D1-489B-9C13-BC6E9F17AC4DQ34820201-E8B0293C-53CF-44F4-92A3-EB542659610BQ35017128-27687524-336A-4B65-823A-005AB2BCE192Q35176011-16E99504-4FB8-4C38-850E-F43FA0AFC2C2Q35415158-A0FD0F35-8292-45CA-9A0A-2DDD96F2BE70Q35575169-D3C24CF4-F3B9-4097-9C52-21764CADB1B0Q35577713-F6905137-9F1F-4B7A-B327-FA59AC91DE24Q35671537-44711B0A-F1A7-4524-9CAC-5E4BCBA4C133Q35765643-907D784C-A98F-41C5-B388-4082AEB686C0Q35892741-F1AB02EA-8831-474C-B780-7C65B8275A68Q35953819-37043D39-6D15-4318-871F-BDE45BD8640DQ36221360-5F6904F0-D1C0-4545-BF4C-B16013832066Q36377442-FA5A7BCD-E183-408B-8DDE-A6FDCEC7DDC8Q36736116-C7411EFA-C426-49F0-B443-613FCF4EA048Q36875417-A59123CD-BF53-45B8-B6C8-CBFBDF649844Q37029550-121A03C0-46C1-4815-9FB0-5F2DCB1AB2F2Q37079363-183F05B6-AC54-49E0-8148-D22359A7C1DDQ37411953-69364EAC-44D0-4E66-97E4-A806B7152536Q37990456-E02EC058-B528-49B0-ABE8-2A6A22B4F66EQ38167646-F982F3C7-61E8-47BF-876F-7D465F65D0D7
P2860
Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Positron emission tomographic ...... ship to cognitive performance.
@en
Positron emission tomographic ...... ship to cognitive performance.
@nl
type
label
Positron emission tomographic ...... ship to cognitive performance.
@en
Positron emission tomographic ...... ship to cognitive performance.
@nl
prefLabel
Positron emission tomographic ...... ship to cognitive performance.
@en
Positron emission tomographic ...... ship to cognitive performance.
@nl
P2093
P2860
P1433
P1476
Positron emission tomographic ...... ship to cognitive performance.
@en
P2093
George A Ricaurte
Hayden T Ravert
Melin Vranesic
Michael Palermo
Robert F Dannals
Una D McCann
William B Mathews
Zsolt Szabo
P2860
P2888
P304
P356
10.1007/S00213-008-1218-4
P577
2008-07-27T00:00:00Z